FDA says it will take “decisive steps” against GLP-1 compounders; Reuters reports HHS refers Hims to US DOJ for investigation Sherwood NewsUS signals crackdown on compounded weight-loss drugs; Hims shares tumble CNBCUS announces crackdown on copycat weight-loss drugs Financial TimesHims & Hers launches Wegovy knockoff pill, drugmaker Novo Nordisk vows to sue PBSFDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report Pharmaceutical Executive